Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml).

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*—Addressing Nationwide Shortage of the Essential Drug Provided by PR Newswire May ...

An ongoing national shortage of albuterol sulfate inhalation solution — the liquid version used in nebulizers for patients unable to use an inhaler, such as infants, who have breathing ...

In late October 2022, the FDA declared a shortage of albuterol sulfate inhalation solution 0.5%, and as of early April the shortage is still in effect, according to the administration’s website ...

Akorn, which operated manufacturing plants in Decatur, New York and New Jersey and a research facility in Vernon Hills, produced albuterol sulfate inhalation solution, used to treat asthma and ...

In this Oct. 14, 2020, file photo, a woman who has an asthma disorder holds a box of inhalation solution of Ipratropium Bromide and Albuterol Sulfate, prescribed medication at her home in Keizer, Ore.

There is a scarcity of a certain albuterol medication product – and the Food and Drug Administration said Wednesday night that it is "working to address" that.

The increasing incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is a significant driver for the Albuterol Sulfate Inhalation Aerosol market. The ...

COLUMBIA, S.C., May 20, 2025 /PRNewswire/ -- Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the largest sterile contract development manufacturing organization (CDMO ...

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug PR Newswire Tue, May 20, 2025 ...